Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Laboratory Investigation

• Publication date

  2005-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/labinvest.3700291PMID 15924153
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis

  2004cited by this paper
• Hypermethylation of death‐associated protein (DAP) kinase CpG island is frequent not only in B‐cell but also in T‐ and natural killer (NK)/T‐cell malignancies

  2003cited by this paper
• Heat stress downregulates FLIP and sensitizes cells to Fas receptor-mediated apoptosis

  2003cited by this paper
• Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) Activates the Phosphatidylinositol 3-Kinase/Akt Pathway to Promote Cell Survival and Induce Actin Filament Remodeling*

  2003cited by this paper
• Cellular FLICE/Caspase-8–Inhibitory Protein as a Principal Regulator of Cell Death and Survival in Human Hepatocellular Carcinoma

  2003cited by this paper
• Frequent mutations of Fas gene in nasal NK/T cell lymphoma

  2002cited by this paper
• Defective death receptor signaling as a cause of tumor immune escape.

  2002cited by this paper
• Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.

  2002cited by this paper
• Selective Inhibition of Dipeptidyl Peptidase I, Not Caspases, Prevents the Partial Processing of Procaspase-3 in CD3-activated Human CD8+ T Lymphocytes*

  2002cited by this paper
• Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.

  2002cited by this paper
• Selective expression of FLIP in malignant melanocytic skin lesions.

  2001cited by this paper
• Phosphatidylinositol 3-Kinase/Akt Activity Regulates c-FLIP Expression in Tumor Cells*

  2001cited by this paper
• Phosphatidylinositol 3-Kinase/Akt Signaling Controls Endothelial Cell Sensitivity to Fas-Mediated Apoptosis via Regulation of FLICE-Inhibitory Protein (FLIP)

  2001cited by this paper
• FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis

  2001cited by this paper
• The Small Heat Shock Protein αB-Crystallin Negatively Regulates Cytochrome c- and Caspase-8-dependent Activation of Caspase-3 by Inhibiting Its Autoproteolytic Maturation*

  2001cited by this paper
• Increased expression of cFLIP(L) in colonic adenocarcinoma.

  2001cited by this paper
• Resistance to Fas-Mediated Apoptosis in EBV-Infected B Cell Lymphomas Is Due to Defects in the Proximal Fas Signaling Pathway1

  2001cited by this paper
• Increased expression of cFLIPL in colonic adenocarcinoma

  2001cited by this paper
• Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95‐mediated apoptosis by down‐regulating FLIP‐L expression

  2000cited by this paper
• Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.

  2000cited by this paper
• Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand.

  1999cited by this paper
• The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors

  1999cited by this paper
• Control of apoptosis by Rel/NF-kappaB transcription factors.

  1999cited by this paper
• Immune Escape of Tumors in Vivo by Expression of Cellular Flice-Inhibitory Protein

  1999cited by this paper
• Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma.

  1999cited by this paper
• Dap-Kinase Participates in TNF-α–And FAS-Induced Apoptosis and Its Function Requires the Death Domain

  1999cited by this paper
• IAPs block apoptotic events induced by caspase‐8 and cytochrome c by direct inhibition of distinct caspases

  1998cited by this paper
• Two CD95 (APO‐1/Fas) signaling pathways

  1998cited by this paper
• Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation.

  1998cited by this paper
• Establishment of an IL‐2‐dependent cell line derived from ‘nasal‐type’ NK/T‐cell lymphoma of CD2+, sCD3−, CD3ɛ+, CD56+ phenotype and associated with the Epstein‐Barr virus

  1998cited by this paper
• Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.

  1998cited by this paper
• REAL classification of malignant lymphomas in the republic of korea

  1998cited by this paper
• Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients.

  1998cited by this paper
• Caspases: enemies within.

  1998cited by this paper
• Inhibition of death receptor signals by cellular FLIP

  1997cited by this paper
• The Epstein–Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB

  1997cited by this paper
• DAP kinase links the control of apoptosis to metastasis

  1997cited by this paper
• The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.

  1997cited by this paper
• Protease activation during apoptosis: death by a thousand cuts?

  1995cited by this paper
• The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

  1995cited by this paper
• Treatment outcome and prognostic factors for primary nasal lymphoma.

  1995cited by this paper
• Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

  1994cited by this paper
• Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes

  1989cited by this paper
• The structure of the human CD2 gene and its expression in transgenic mice.

  1988cited by this paper
• An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

  1985cited by this paper
• Role of NF- (cid:2) B in Cell Survival and Transcription of Latent Membrane Protein 1-Expressing or Epstein-Barr Virus Latency III-Infected Cells

  year unknowncited by this paper

• Functional screening of somatic mutant events in extranodal natural killer/T-cell lymphoma with adrenal involvement

  2025cites this paper
• Efficient recruitment of c‐FLIPL to the death‐inducing signaling complex leads to Fas resistance in natural killer‐cell lymphoma

  2020cites this paper
• EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts

  2018cites this paper
• Molecular Pathogenesis of Peripheral T Cell Lymphoma

  2015cites this paper
• T-CELL AND OTHER LYMPHOPROLIFERATIVE MALIGNANCIES ( P PORCU , SECTION EDITOR ) Molecular Pathogenesis of Peripheral T Cell Lymphoma

  2015cites this paper
• JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma

  2014cites this paper
• Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.

  2013cites this paper
• Immunohistochemistry of Programmed Cell Death in Archival Human Pathology Specimens

  2012cites this paper
• Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy

  2011cites this paper
• Specific downregulation of death-associated protein kinase enhances Fas-mediated apoptosis in the human differentiated endometrial adenocarcinoma cell line, HHUA.

  2011cites this paper
• Anti-CD3 recombinant diphtheria immunotoxin therapy of cutaneous T cell lymphoma.

  2009cites this paper
• Natural killer-cell neoplasms

  2009cites this paper
• Possible role for external environmental stimuli in nasopharyngeal NK/T-cell lymphomas in the northeast of China with EBV infection-related autophagic cell death: a pathoepidemiological analysis.

  2009cites this paper
• STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma

  2009cites this paper
• Conversion of CD95 (Fas) Type II into Type I signaling by sub-lethal doses of cycloheximide.

  2008cites this paper
• Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.

  2008cites this paper
• Homeostatic Mass Control in Gastric Non-Neoplastic Epithelia under Infection of Helicobacter pylori: An Immunohistochemical Analysis of Cell Growth, Stem Cells and Programmed Cell Death

  2008cites this paper
• The heat‐shock protein 90 inhibitor, geldanamycin, induces apoptotic cell death in Epstein–Barr virus‐positive NK/T‐cell lymphoma by Akt down‐regulation

  2007cites this paper
• Granzyme B leakage-induced apoptosis is a crucial mechanism of cell death in nasal-type NK/T-cell lymphoma

  2007cites this paper
• Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia.

  2007cites this paper
• Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells.

  2006cites this paper
• cFLIP expression correlates with tumour progression and patient outcome in non‐Hodgkin lymphomas of low grade of malignancy

  2006cites this paper